Pricing Log in Create free account

Lakefront Biotherapeutics - Sponsored ADR (LKFT) vs First Tracks Biotherapeutics, Inc. (TRAX)

Lakefront Biotherapeutics - Sponsored ADR and First Tracks Biotherapeutics, Inc. are both Biotechnology companies. Lakefront Biotherapeutics - Sponsored ADR and First Tracks Biotherapeutics, Inc. are of similar size ($2.2B and $2.2B). First Tracks Biotherapeutics, Inc. has the higher net margin (0.00% vs −6.81%) and the higher return on invested capital (0.00% vs 0.00%). Across the 7 metrics below, First Tracks Biotherapeutics, Inc. leads on 4 and Lakefront Biotherapeutics - Sponsored ADR on 3.

Valuation

Metric LKFT TRAX Biotechnology median
P/E n/m n/m 11.58
P/S 7.79 n/m 9.61
P/B 0.58 11.90 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA 0.96 n/m 0.72
EV/Sales (1.42) n/m 9.43
Earnings yield (0.85%) (10.29%) (32.28%)
Free cash flow yield (27.15%) (6.25%) (22.27%)

Profitability

Metric LKFT TRAX Biotechnology median
Gross margin 89.75% — 68.81%
Operating margin (90.11%) 0.00% 0.00%
Net margin (6.81%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (50.30%)
Return on assets 0.00% 0.00% (45.47%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LKFT TRAX Biotechnology median
Revenue growth (TTM) (52.22%) — 6.78%
EPS growth (last fiscal year) 355.37% — 29.88%
Revenue growth, 5-year CAGR 15.75% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric LKFT TRAX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 32.84 9.16 4.74
Net debt to EBITDA (8.53) — 1.01

Dividend

Metric LKFT TRAX Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric LKFT TRAX Biotechnology median
Market cap 2.19b 2.20b 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack